Showing 581 - 600 results of 44,127 for search '(( 5 ((mean decrease) OR (nn decrease)) ) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 0.75s Refine Results
  1. 581
  2. 582
  3. 583
  4. 584
  5. 585

    Rapamycin decreases phosphorylation of downstream targets of mTOR in the skin. by Lydia Jiménez-Díaz (44306)

    Published 2008
    “…The <i>y</i> axis represents the percentage of normalised phospho-S6K pixels above a threshold of 50. Measurements were made from confocal images as in <i>B</i>. …”
  6. 586
  7. 587
  8. 588
  9. 589

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  10. 590

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  11. 591
  12. 592

    Decreased number of NeuN-positive neurons in the hippocampi of <i>Rere</i><sup>om/eyes3</sup> embryos. by Bum Jun Kim (381759)

    Published 2013
    “…B) Brain sections through the hippocampi of wild-type and <i>Rere</i><sup>om/eyes3</sup> embryos were probed with anti-NeuN antibody (green color) at E18.5. Decreased numbers of NeuN-positive cells are seen in CA fields of the hippocampus from <i>Rere</i><sup>om/eyes3</sup> embryos compared to those from wild-type embryos. …”
  13. 593
  14. 594
  15. 595
  16. 596
  17. 597

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
  18. 598

    HDM exposure results in increased MIP-2 and decreased IFNα and IL-13. by Jennifer A. Phan (535730)

    Published 2014
    “…HDM exposure increased bronchoalveolar lavage MIP-2 (A), and decreased IFNα (B) and IL13 (C). There was no effect of HDM exposure on BAL protein (D), nor were there any effects of HRV-1B infection alone, or combined effects of HDM exposure and HRV-1B infection on any of these parameters. * indicates a significant difference between groups. …”
  19. 599
  20. 600